Lataa...
Management of Fibrosing Interstitial Lung Diseases
A proportion of patients with interstitial lung diseases (ILDs), including the ILDs that are commonly associated with autoimmune diseases, develop a progressive fibrosing phenotype characterised by worsening of lung function, dyspnoea and quality of life, and early mortality. No drugs are approved f...
Tallennettuna:
| Julkaisussa: | Adv Ther |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Healthcare
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6824393/ https://ncbi.nlm.nih.gov/pubmed/31119691 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-019-00992-9 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|